Changshan Yuzhong Plastic Products Co., Ltd – Trademark Portfolio

Entity Type: 99

Changshan Yuzhong Plastic Products Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include JINHANTONG. The owner is based in Zhejiang Province.

(Factory Building No. 8),No. 15,Longjiang Road,Jinchuan Street,Changshan County, Quzhou City

Zhejiang Province 324000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Changshan Yuzhong Plastic Products Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Changshan Yuzhong Plastic Products Co., Ltd have?

Changshan Yuzhong Plastic Products Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Changshan Yuzhong Plastic Products Co., Ltd file in?

Changshan Yuzhong Plastic Products Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Changshan Yuzhong Plastic Products Co., Ltd's most well-known trademarks?

Changshan Yuzhong Plastic Products Co., Ltd's registered trademark portfolio includes well-known marks such as JINHANTONG. These are among 1 currently registered trademark in the portfolio.

What is Changshan Yuzhong Plastic Products Co., Ltd's trademark registration success rate?

Changshan Yuzhong Plastic Products Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.